Reply: Mode of Death Prevention by Serelaxin.
Publication
, Journal Article
Felker, GM; Metra, M; Teerlink, JR
Published in: J Am Coll Cardiol
July 7, 2015
Duke Scholars
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
July 7, 2015
Volume
66
Issue
1
Start / End Page
99
Location
United States
Related Subject Headings
- Relaxin
- Male
- Humans
- Heart Failure
- Female
- Death, Sudden, Cardiac
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Felker, G. M., Metra, M., & Teerlink, J. R. (2015). Reply: Mode of Death Prevention by Serelaxin. J Am Coll Cardiol, 66(1), 99. https://doi.org/10.1016/j.jacc.2014.12.078
Felker, G Michael, Marco Metra, and John R. Teerlink. “Reply: Mode of Death Prevention by Serelaxin.” J Am Coll Cardiol 66, no. 1 (July 7, 2015): 99. https://doi.org/10.1016/j.jacc.2014.12.078.
Felker GM, Metra M, Teerlink JR. Reply: Mode of Death Prevention by Serelaxin. J Am Coll Cardiol. 2015 Jul 7;66(1):99.
Felker, G. Michael, et al. “Reply: Mode of Death Prevention by Serelaxin.” J Am Coll Cardiol, vol. 66, no. 1, July 2015, p. 99. Pubmed, doi:10.1016/j.jacc.2014.12.078.
Felker GM, Metra M, Teerlink JR. Reply: Mode of Death Prevention by Serelaxin. J Am Coll Cardiol. 2015 Jul 7;66(1):99.
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
July 7, 2015
Volume
66
Issue
1
Start / End Page
99
Location
United States
Related Subject Headings
- Relaxin
- Male
- Humans
- Heart Failure
- Female
- Death, Sudden, Cardiac
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology